PLBY vs SRPT · rev $61.5M vs rev $1.13B
Plby Group Inc (PLBY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Plby Group Inc (PLBY) is a leisure company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PLBY revenue for 2026-06-30 was $61.5M. Net income was -$3.8M. PLBY currently screens at market cap $155.9M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
PLBY currently screens at market cap $155.9M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PLBY and SRPT stock pages for the full models.
Not investment advice.